Results from Phase 3 trials for non-infectious uveitis treatment ➤ FDA allows new gene therapy for Leber congenital amaurosis to begin clinical testing ➤ FDA approves OTC drop for redness ➤ Company ne ...

The John A. Moran Eye Center ophthalmology residents reviewed “Long-term outcomes of corneal crosslinking for keratoconus across pediatric, adolescent, and adult populations in a diverse U.S.

“You can’t really know where you are going until you know where you have been.” This adage applies to a paper recently published in the Journal of Cataract & Refractive Surgery (JCRS), adding to the ...

Being successful in ophthalmology goes beyond just providing excellent clinical care, and learning and teaching has a ...

The John A. Moran Eye Center ophthalmology residents reviewed “Long-term outcomes of corneal crosslinking for keratoconus ...

Glaukos presented positive topline results from its Phase 3 extension study, which followed for 3 years a cohort of patients with keratoconus who received epithelium-on crosslinking with Epioxa ...

Karl Deisseroth, MD, PhD, Peter Hegemann, PhD, and Georg Nagel, PhD, were awarded the Nobel Prize in Physiology or Medicine “for their discoveries concerning light-gated ion channels and optogenetics.

Rayner announced FDA approval of its RayOne Galaxy and RayOne Galaxy Toric IOLs on what it described as the “world’s first spiral IOL platform.” According to the company’s press release the Galaxy is ...

Refractive cataract surgery continues to advance on the techniques and technologies we use to improve visual quality in our patients. This is particularly evident when discussing IOL technologies, ...

Discussing the device further in a Q&A, Dr. Mah noted that the EndoArt has been well received in Europe. Once you start getting used to it, the indications start expanding if you get good results and ...